Infection control supplies are essential to prevent cross contamination and maintain sterile fields for procedures.
Locate hand hygiene stations at room entry and near the patient table and provide single use sterile barriers.
Implement cleaning checklists between patients and use approved disinfectants for equipment and surfaces.
Train staff on aseptic technique room turnover and documentation of cleaning and sterilization activities.
Bohrium is a synthetic element created to investigate the properties of superheavy elements and test periodic trends in group 7.
Predicted to show chemistry similar to rhenium and other group 7 elements, with possible +7 oxidation states under specific conditions.
No commercial uses; produced in accelerator facilities for fundamental research in nuclear and atomic physics.
Bohrium isotopes are radioactive and short lived; experiments require remote handling, containment and radiological safeguards.
Barium swallow evaluates oropharyngeal transfer esophageal motility and structural lesions with dynamic imaging during swallowing.
Include thin and thick bolus swallows lateral and anterior posterior views and timed sequences to assess aspiration and clearance.
Used for dysphagia evaluation postoperative assessment and planning for speech therapy or surgical intervention.
Use pulsed fluoroscopy minimize exposure and tailor study length to clinical question while ensuring diagnostic completeness.
Niobium is a soft, gray transition metal valued for its superconducting properties and ability to strengthen steel when alloyed.
It commonly exhibits a +5 oxidation state, has good corrosion resistance and contributes to high temperature strength in alloys.
Found in minerals such as columbite and pyrochlore, niobium is used in superalloys, superconducting magnets and specialty steels.
Stable isotope Nb 93 predominates; niobium metal is of low toxicity though fine powders require handling controls.
Development managers cultivate donor relationships, design fundraising initiatives and coordinate events and communications to secure philanthropic support for programs and capital projects.
They identify prospects, steward existing donors, prepare proposals and coordinate advisory boards and campaigns to align donor interests with institutional priorities.
Managers oversee gift processing, donor recognition, compliance with charitable regulations and reporting to leadership and trustees on fundraising performance.
Roles typically require experience in nonprofit fundraising, strong communication and relationship building skills and the ability to translate clinical needs into compelling philanthropic cases.
Mn DPDP is a manganese based MRI contrast agent that provided hepatocyte uptake and T1 shortening for liver lesion characterization.
Manganese acts as a paramagnetic ion producing T1 shortening; agent had partial hepatocellular uptake and biliary excretion.
Used for liver MRI to improve detection and characterization of focal hepatic lesions when available.
Use limited by availability and concerns about manganese toxicity in severe hepatic dysfunction; follow regulatory status and local availability.
Neodymium is a rare earth metal essential for high performance permanent magnets used in motors and electronics.
It forms +3 ions, alloys readily to produce strong magnetic materials and has important optical properties in glass.
Neodymium is used in magnets for wind turbines, electric vehicles, headphones and lasers and in specialty glass.
Stable isotopes include Nd 142 to Nd 150; neodymium compounds are handled with standard industrial safety measures.
Technetium 99m HMPAO is a lipophilic radiopharmaceutical used for brain perfusion imaging and for labeling leukocytes in infection imaging.
Tc 99m HMPAO crosses the blood brain barrier transiently and is retained in brain tissue proportional to regional blood flow; emits gamma photons for SPECT.
Used for cerebral perfusion SPECT in stroke and dementia evaluation and for leukocyte labeling to localize infection or inflammation.
Radiation exposure is low but present; follow nuclear medicine safety protocols and screen for pregnancy and breastfeeding.
PET MRI integrates metabolic PET data with high soft tissue contrast MRI to improve lesion characterization and staging. The hybrid modality reduces radiation compared with PET CT for some indications and offers simultaneous multiparametric assessment. Clinical workflows require coordinated protocols and scheduling.
PET MRI is valuable in neuro oncology for tumor delineation and in pediatric oncology to reduce radiation exposure. It supports cardiac sarcoidosis assessment and whole body oncologic staging in select cases. Multiparametric MRI sequences add functional and structural context to PET findings.
Hybrid scanners require synchronized acquisition protocols and expertise in both PET and MRI physics and safety. Attenuation correction methods and motion correction are technical challenges that affect quantification. Scheduling and throughput considerations influence cost effectiveness and utilization.
Advances in tracer development and quantitative PET MRI biomarkers may expand clinical indications and research applications. Integration with AI for image fusion and automated quantification will streamline interpretation. Comparative effectiveness studies will clarify optimal use cases and reimbursement pathways.
Immunotherapy can produce atypical response patterns such as pseudoprogression which complicates assessment by size alone. Imaging biomarkers including radiomics PET metrics and functional MRI parameters may provide earlier indicators of response or resistance. Robust validation is required before clinical adoption.
PET based metrics of metabolic activity and radiomic texture features from CT or MRI have shown promise in early studies. Dynamic contrast MRI and diffusion metrics may reflect changes in tumor microenvironment and immune infiltration. Combining imaging biomarkers with blood based markers may improve predictive performance.
Prospective trials with standardized imaging protocols are needed to validate biomarkers and define thresholds for clinical decisions. Harmonization across scanners and reconstruction methods is essential for reproducibility. Regulatory qualification pathways should be pursued for biomarkers intended as trial endpoints.
Imaging biomarkers can inform early treatment modification and trial stratification when validated and standardized. Implement biomarker reporting with clear interpretation and recommended actions for clinicians. Multidisciplinary tumor boards should incorporate biomarker data into decision making.
